Blogroll

Washington, D.C. on Wednesday urged people who had participated in protests against police brutality and systematic racism to get tested for the coronavirus.

The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Facebook , Google and Twitter should provide monthly reports on their fight against disinformation, two senior EU officials said on Wednesday as they called out Russia and China for their roles in the spread of fake news.

A group of U.S. lawmakers preparing to fight a legislative attack on encrypted communications is trying to establish what happened when encryption was subverted at a Silicon Valley maker of networking gear.

France's new death toll from COVID-19 on Wednesday was only one-third of the tally the day before but the total of new confirmed infections rose again, one month out of a strict lockdown.

The U.S. Centers for Disease Control and Prevention (CDC) on Wednesday reported 1,973,797 cases of the new coronavirus, an increase of 17,376 cases from its previous count, and said that the number of deaths had risen by 950 to 112,133.

A group representing relatives of people who died of COVID-19 in Bergamo, one of Italy's hardest-hit cities, asked prosecutors on Wednesday to investigate possible criminal responsibility in the management of the pandemic.

Zara owner Inditex unveiled a 2.7 billion euro ($3 billion) investment in technology on Wednesday to make it easier for customers to track the items they want, blurring the lines between online and in-store shopping.

European food ordering firm Just Eat Takeaway.com NV said on Wednesday it was in advanced talks to buy Grubhub Inc in an all-stock deal that, if completed, would create the world's largest food delivery company by revenue.

Johnson & Johnson moved up the start of human clinical trials for its experimental vaccine against the highly contagious coronavirus by two months to the second half of July, as the drugmaker rushes to develop a prevention for COVID-19, the company said on Wednesday.

A team of Polish scientists has designed a remote-controlled ventilator they hope will allow doctors to help critically ill patients breathe, but from a distance, in a bid to make medical personnel safer during the coronavirus pandemic.

A potential COVID-19 vaccine being developed by Chinese researchers showed promise in trials in monkeys, triggering antibodies and raising no safety issues, researchers said, and a human trial with more than 1,000 participants is under way.

Arizona again told hospitals to activate the coronavirus emergency plans after cases spiked following reopening, turning it into a U.S. virus hotspot along with neighboring Southwest states.

It is unclear how the arrival of winter in the southern hemisphere will impact the novel coronavirus, the head of the World Health Organization's emergencies programme Mike Ryan said on Wednesday.

Chinese video app TikTok's practices are to be examined by an EU task force, the bloc's privacy watchdog said on Wednesday, which also warned EU police forces against using facial recognition software from U.S. company Clearview AI.

Britain's competition regulator has given itself two more months to make a final ruling on Amazon's purchase of a minority stake in online delivery group Deliveroo so it can take full account of representations from all interested parties.

The National Institutes of Health (NIH) on Wednesday launched a study to evaluate drugs prescribed to treat COVID-19, the respiratory disease caused by the new coronavirus, among children and adolescents across the United States.

Johnson & Johnson said on Wednesday it would bring forward by two months human trials of its potential COVID-19 vaccine to the second half of July, as the drugmaker rushes to develop a shot for the contagious respiratory disease.

Scientists have used human embryonic stem cells to create an embryo-like research model to help them study some of the earliest stages of human development.

Abbvie Inc said on Wednesday it is partnering with Danish biotech firm Genmab AS to jointly develop and market cancer treatments, as it looks to expand its cancer franchise.